AI Denials: Systemic Risk, Patient Harm, & Liability Exposure

AI was pitched to healthcare as a tool for efficiency, but its rollout in prior authorization is now a source of huge controversy. When you let algorithms make care decisions, you create systemic risks, mainly patients being denied necessary services and providers getting stuck with the liability. We’re going to break down the regulatory and litigation risks that come with automated insurance decisions, because unchecked AI is turning into a fantastic way to destroy enterprise value.

The Rise of Algorithmic Denials and Their Human Cost

Prior authorization has always been a point of friction between payers and providers, a process meant to manage costs by double-checking if treatments are medically necessary. The problem is, using AI algorithms to speed up these reviews has just led to a flood of automated denials, many with no real human check. This is more than a paperwork problem. It directly hurts patients, causing delays and sometimes preventing access to care they absolutely need. The American Medical Association (AMA) has been sounding the alarm on this for years, showing how the administrative weight of prior auth directly slows down patient care. Their AMA survey data on prior authorization burden is pretty damning: more than a quarter of physicians (26%) say prior auth led to a serious adverse event for a patient, which could mean hospitalization, permanent harm, or even death. On top of that, 95% of doctors report that these processes delay access to necessary care. When a black-box algorithm is spitting out these denials, the lack of transparency and accountability just makes a bad situation worse.

Regulatory Scrutiny and Enforcement Actions

The Office of Inspector General (OIG) has become the main watchdog here, zeroing in on Medicare Advantage plans and their absurdly high rates of prior authorization denials. OIG reports have consistently found that these plans deny services that are clearly covered under Medicare rules, and the proof is in the appeals: an incredible 95% of appealed denials for skilled nursing facility admissions were later overturned, siding with the patient. That’s a huge red flag that people were initially denied care they were entitled to, suggesting the algorithms are tuned way too aggressively to contain costs, not to meet patient needs. In response, the Centers for Medicare & Medicaid Services (CMS) issued a final rule, the Interoperability and Prior Authorization Final Rule (CMS-0057-F), which took effect on January 1, 2026. This isn’t a minor tweak. The rule forces faster decisions (72 hours for urgent requests, seven calendar days for standard ones) and, more importantly, requires payers to give specific reasons for denials and publicly report their prior authorization metrics. For private equity firms and compliance officers in healthcare, this regulatory tightening is a clear warning shot about the growing enforcement risk for any system that doesn’t put patient safety first.

Litigation Risks: UnitedHealth Group and Cigna Under the Microscope

The use of automated denial algorithms is also becoming a magnet for class-action lawsuits, putting major payers like UnitedHealth Group and Cigna in serious legal and reputational trouble. These companies have been hammered with accusations that their AI systems are set up to systematically deny care that patients need. A major class-action suit filed in November 2023 against UnitedHealth Group’s subsidiary NaviHealth is still going. The lawsuit claims NaviHealth’s AI model, “nH Predict,” was used to prematurely end coverage for Medicare Advantage patients who needed post-acute care. The complaint’s central argument is that the algorithm, which was built to predict when a patient could be discharged, was used to ignore doctors’ recommendations and Medicare’s own guidelines, resulting in wrongful denials. Plaintiffs even allege the nH Predict model has a 90% error rate, meaning that for every ten claims it denied, nine were eventually approved after an appeal. The case took a turn in March 2026, when a federal judge ordered UnitedHealth to turn over a huge volume of internal documents about how the algorithm works. This is a perfect example of algorithmic drift, where a model trained on a clean dataset completely fails when faced with the complexity of real-world patients, leading to bad outcomes and, in this case, massive legal exposure. Cigna is in a similar boat, facing its own legal battles over automated claims processing. A 2023 class-action suit alleges Cigna deployed an algorithm called “PxDx” to reject hundreds of thousands of claims in just seconds, with no real individual review. The case got a green light in March 2025 when a U.S. District Court ruled that Cigna’s argument that it could use an algorithm while still having a medical director technically “make” the decision was an “abuse of discretion.” As if that wasn’t enough, in March 2026, the Maryland Insurance Administration fined Cigna, ordering the company to stop its “automatic down-coding” policy and reprocess all the claims it had affected. What’s the point of an algorithm if it just gets things wrong faster? These cases bring up serious ethical questions about using AI in healthcare, especially when it seems the goal is processing speed over sound clinical judgment. The risk for companies isn’t just paying for lawyers. It’s the potential for massive damages, government fines, and a complete collapse of trust with patients and doctors. The precedents set here will absolutely define the future of AI in health insurance.

Enterprise Value at Risk: The Financial Implications of Unchecked AI

For any private equity investor or risk officer looking at the healthcare space, these issues should be keeping you up at night. Those automated denial tools might look good on a spreadsheet by promising cost savings, but they come with regulatory and litigation risks that can wipe out enterprise value. A company’s proprietary AI model, that so-called data moat, quickly becomes a huge liability if it’s found to systematically harm patients or break regulations. The penalties from an OIG investigation, combined with a nine-figure settlement from a class-action suit, can be financially devastating. And that’s just the direct costs. The intangible damage can be even worse. A trashed reputation, angry doctors who refuse to work with you, and patients who don’t trust you can cripple your market position for years. The extra administrative work dumped on providers to fight opaque and often-wrong automated denials also poisons payer-provider relationships, making it harder to build networks and ensure patients can get care. If you’re going to use AI for critical decisions like prior authorization, you need strong governance, transparency about how the models work, and a clear, simple process for human review and appeals. Without those guardrails, chasing automated efficiency is just asking for legal and financial disaster.

Methodology and Source Note

This analysis is built on verified regulatory documents, like OIG investigative reports on Medicare Advantage denials, and federal court filings from the class-action lawsuits against major payers. It’s also informed by insights from American Medical Association (AMA) surveys on how prior authorization burdens doctors and delays care. This whole piece is written from a risk-analysis perspective, focused on the real-world legal and financial fallout from these automated systems. The systemic risks from automated insurance denials are very real. We’re seeing them play out in federal investigations, class-action lawsuits, and, most importantly, in patients not getting the care they need. Anyone deploying or investing in AI for healthcare payers has to understand these risks. Responsible AI, which means clinical validation, transparent methods, and strong human oversight, isn’t just a “best practice.” It’s a critical defense against regulatory and litigation disasters. White Paper on Responsible AI in Healthcare The future of AI in healthcare will depend on whether it helps or hurts patient well-being, and that means companies need to get serious about managing these risks now.